Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology
Annika Schneider, Julia Wortmann, Cecilia Bang Jensen, Leonardo Estrada Duenas, Maria‐Veronica Teleanu, Amirhossein Sakhteman, Firas Hamood, Florian P Bayer, Christoph Stange, Jeremiah Bintang Santoso, Jennifer Hüellein, Nindo B. Punturi, Lee Dolat, Peter Horak, Resch Moritz, , Bernhard Küster
This study uses pan-cancer phosphoproteomics to identify therapeutic targets and improve precision oncology by analyzing 1,998 tumor samples and developing new scores for kinase activity and immune response.
bioRxiv · Jul 9, 2026 · PreprintCancer Biology